He recently demonstrated a prototype of cancer metalloimmunotherapy by using manganese (Mn2+) that has been proven to effectively activate the cGAS-STING signaling pathway (Lv et al., 2020; Zhao et al., 2020; Sun et al., 2021). Here, STING1 is linked to cancer.